Pollack surprised by positive test, denies wrongdoing

Olaf Pollack (Team Volksbank)

Olaf Pollack (Team Volksbank) (Image credit: Isabelle Duchesne)

Former German T-Mobile and Gerolsteiner rider Olaf Pollack has reacted with "surprise" to his positive anti-doping test from July 6, which was revealed by the German cycling federation (BDR) yesterday. In a statement, the 35-year-old denied having used any banned substances.

"I cannot explain the alleged test result," said Pollack, who has vowed to clear his name. "I have told the BDR I will cooperate in the investigation of this case. Moreover, I have requested the analysis of the B-sample, which I will attend in the presence of a scientific expert."

But the German road and track rider also criticised the BDR's swift publication of his positive A-sample. "I was taken aback by the BDR's announcement of a temporary suspension, which encourages public prejudice. I regret this step also because of the following reason: The BDR is aware of the fact that I am currently undergoing treatment for a serious illness."

Pollack's recent successes on the track (Silver medal in the Madison at the 2008 World Championships in Manchester, German champion in the Madison and points race) were brought to a halt when the rider had to go to hospital for an eye infection in mid-August. However, his condition (retinal detachment) worsened and Pollack may be forced to end his career because of it.

Pollack risks a two-year suspension if the B-sample also returns positive for a yet unnamed substance.

Follow Cyclingnews on Twitter for the very latest coverage of events taking place in the cycling world - twitter.com/cyclingnewsfeed

Thank you for reading 5 articles in the past 30 days*

Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read any 5 articles for free in each 30-day period, this automatically resets

After your trial you will be billed £4.99 $7.99 €5.99 per month, cancel anytime. Or sign up for one year for just £49 $79 €59

Join now for unlimited access

Try your first month for just £1 / $1 / €1